Foundation Medicine and Flatiron Health team up for genomic profiling platform; 23andMe scores approval in the U.K.;

> Foundation Medicine ($FMI) and Flatiron Health are teaming up to create a cloud-based, genomic profiling platform that could help develop targeted cancer therapies. Release

> California genetics outfit 23andMe won approval from the U.K.'s Research Ethics Committee to launch its full Personal Genome Service in the country. Story

> Philips ($PHG) launched a new lung screening solution for lung cancer detection and treatment. More

> The FDA slapped Siemens ($SIE) with a Class I recall for some of its gram negative bacteria panels. Notice

> Hologic scored a CE mark for its new HIV viral load assay for diagnosis and treatment monitoring. Story

> Genomics raised £10.3 million ($12.8 million) in a private round to develop its platform for genomic sequence data analysis. Story

> The National Institutes of Health is funding research aimed at developing a low-cost, electricity-free device that can identify the DNA of infectious pathogens. Story

> BridgeCrest Medical is partnering with JAJ International to roll out its rapid one-step test for Ebola. Release